Chemed Co. (NYSE:CHE) Shares Bought by Cerity Partners LLC

Cerity Partners LLC increased its position in Chemed Co. (NYSE:CHE) by 13.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 959 shares of the company’s stock after acquiring an additional 110 shares during the quarter. Cerity Partners LLC’s holdings in Chemed were worth $522,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. FMR LLC raised its stake in shares of Chemed by 18.9% during the 4th quarter. FMR LLC now owns 283,790 shares of the company’s stock worth $150,352,000 after buying an additional 45,174 shares during the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in shares of Chemed in the fourth quarter valued at about $130,000. Waterloo Capital L.P. grew its position in shares of Chemed by 10.4% in the fourth quarter. Waterloo Capital L.P. now owns 2,776 shares of the company’s stock valued at $1,471,000 after purchasing an additional 261 shares during the last quarter. Russell Investments Group Ltd. increased its stake in shares of Chemed by 40.4% during the 4th quarter. Russell Investments Group Ltd. now owns 21,127 shares of the company’s stock worth $11,193,000 after purchasing an additional 6,084 shares in the last quarter. Finally, Resona Asset Management Co. Ltd. purchased a new stake in Chemed in the 4th quarter valued at approximately $1,368,000. 95.85% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CHE. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research report on Friday, March 7th. Royal Bank of Canada lifted their price target on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a report on Friday, March 14th.

Chemed Stock Down 3.2 %

Shares of NYSE:CHE opened at $563.30 on Tuesday. The business has a fifty day simple moving average of $586.59 and a 200-day simple moving average of $567.32. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $623.61. The company has a market cap of $8.23 billion, a P/E ratio of 28.46, a P/E/G ratio of 2.15 and a beta of 0.49.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a dividend of $0.50 per share. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.36%. Chemed’s payout ratio is currently 10.05%.

Insider Buying and Selling

In other news, CEO Kevin J. Mcnamara sold 1,000 shares of the company’s stock in a transaction on Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the completion of the sale, the chief executive officer now directly owns 101,679 shares in the company, valued at $62,566,139.07. This represents a 0.97 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 3.32% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.